Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,149 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Utility of a breast biopsy clip and a point marker system in tailored axillary surgery for patients with breast cancer after neoadjuvant chemotherapy.
Endo Y, Kotani H, Tamura N, Tanaka K, Kudo C, Sawaki M, Hattori M, Yoshimura A, Kataoka A, Nozawa K, Ozaki Y, Isogai A, Komaki R, Nakakami A, Kureyama N, Kusudo M, Hosoda W, Kawabata H, Iwata H. Endo Y, et al. Among authors: ozaki y. Breast Cancer. 2024 Nov;31(6):1130-1136. doi: 10.1007/s12282-024-01630-1. Epub 2024 Sep 23. Breast Cancer. 2024. PMID: 39312110
Effects of neoadjuvant chemotherapy on operative adverse events and chemotherapy and radiotherapy in patients undergoing immediate breast reconstruction.
Adachi Y, Okumura S, Sawaki M, Hattori M, Yoshimura A, Gondo N, Kotani H, Iwase M, Kataoka A, Sugino K, Horisawa N, Ozaki Y, Endo Y, Sakamoto S, Iwata H. Adachi Y, et al. Among authors: ozaki y. Breast Cancer. 2020 Jul;27(4):716-723. doi: 10.1007/s12282-020-01065-4. Epub 2020 Mar 11. Breast Cancer. 2020. PMID: 32162180
The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR status.
Horisawa N, Adachi Y, Takatsuka D, Nozawa K, Endo Y, Ozaki Y, Sugino K, Kataoka A, Kotani H, Yoshimura A, Hattori M, Sawaki M, Iwata H. Horisawa N, et al. Among authors: ozaki y. Breast Cancer. 2022 Mar;29(2):234-241. doi: 10.1007/s12282-021-01303-3. Epub 2021 Oct 7. Breast Cancer. 2022. PMID: 34622383
A case of radiation-associated angiosarcoma after breast cancer.
Horisawa N, Adachi Y, Sawaki M, Hattori M, Yoshimura A, Gondo N, Kotani H, Kataoka A, Sugino K, Mori M, Terada M, Ozaki Y, Iwata H. Horisawa N, et al. Among authors: ozaki y. Surg Case Rep. 2018 Nov 7;4(1):131. doi: 10.1186/s40792-018-0538-9. Surg Case Rep. 2018. PMID: 30406473 Free PMC article.
Amyloid tumor of the breast.
Mori M, Kotani H, Sawaki M, Hattori M, Yoshimura A, Gondo N, Adachi Y, Kataoka A, Sugino K, Horisawa N, Terada M, Ozaki Y, Iwata H. Mori M, et al. Among authors: ozaki y. Surg Case Rep. 2019 Feb 19;5(1):31. doi: 10.1186/s40792-019-0591-z. Surg Case Rep. 2019. PMID: 30783867 Free PMC article.
Patient-reported outcomes and objective assessments with arm measurement and bioimpedance analysis for lymphedema among breast cancer survivors.
Terada M, Yoshimura A, Sawaki M, Hattori M, Naomi G, Kotani H, Adachi Y, Iwase M, Kataoka A, Sugino K, Mori M, Horisawa N, Ozaki Y, Iwata H. Terada M, et al. Among authors: ozaki y. Breast Cancer Res Treat. 2020 Jan;179(1):91-100. doi: 10.1007/s10549-019-05443-1. Epub 2019 Sep 18. Breast Cancer Res Treat. 2020. PMID: 31535321
2,149 results